EntryPoint Capital LLC Makes New $894,000 Investment in Masimo Corporation $MASI

Key Points

• EntryPoint Capital LLC invested approximately $894,000 in Masimo Corporation during the first quarter, acquiring 5,368 shares, which now constitutes 0.4% of its portfolio.
• Director William R. Jellison purchased 3,000 shares of Masimo stock, increasing his ownership by 167.60%, with total shares now valued at about $699,244.20.
• Analysts have a consensus rating of "Moderate Buy" for Masimo, with an average price target of $193.60, and several firms have recently adjusted their price expectations for the stock.

EntryPoint Capital LLC acquired a new position in shares of Masimo Corporation (NASDAQ:MASI - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,368 shares of the medical equipment provider's stock, valued at approximately $894,000. Masimo comprises approximately 0.4% of EntryPoint Capital LLC's holdings, making the stock its 8th biggest position.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Farther Finance Advisors LLC grew its stake in shares of Masimo by 128.9% during the first quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock worth $35,000 after buying an additional 116 shares during the last quarter. NBC Securities Inc. acquired a new stake in shares of Masimo during the 1st quarter valued at $61,000. UMB Bank n.a. grew its position in Masimo by 134.0% during the 1st quarter. UMB Bank n.a. now owns 447 shares of the medical equipment provider's stock worth $74,000 after acquiring an additional 256 shares during the last quarter. GAMMA Investing LLC increased its holdings in Masimo by 58.4% in the 1st quarter. GAMMA Investing LLC now owns 738 shares of the medical equipment provider's stock worth $123,000 after purchasing an additional 272 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new position in Masimo in the fourth quarter valued at about $163,000. Institutional investors own 85.96% of the company's stock.

Insider Activity

In related news, Director William R. Jellison acquired 3,000 shares of the firm's stock in a transaction that occurred on Monday, August 11th. The stock was acquired at an average price of $145.98 per share, for a total transaction of $437,940.00. Following the completion of the acquisition, the director owned 4,790 shares of the company's stock, valued at approximately $699,244.20. This represents a 167.60% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 16.90% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages recently issued reports on MASI. Wall Street Zen lowered shares of Masimo from a "buy" rating to a "hold" rating in a report on Friday, May 30th. BTIG Research reaffirmed a "buy" rating on shares of Masimo in a research note on Thursday, August 14th. Piper Sandler lifted their price target on shares of Masimo from $200.00 to $210.00 and gave the stock an "overweight" rating in a report on Wednesday, August 6th. Wells Fargo & Company decreased their price objective on Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a report on Wednesday, May 7th. Finally, Raymond James Financial cut their target price on Masimo from $204.00 to $185.00 and set an "outperform" rating on the stock in a report on Wednesday, May 7th. Five investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $193.60.

Masimo Trading Down 1.9%

Shares of Masimo stock traded down $2.7850 on Monday, reaching $145.8450. 122,236 shares of the company's stock were exchanged, compared to its average volume of 631,671. The company has a market capitalization of $7.92 billion, a P/E ratio of -17.10 and a beta of 1.21. Masimo Corporation has a 52 week low of $107.98 and a 52 week high of $194.88. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.61 and a current ratio of 2.14. The firm's 50-day moving average is $159.19 and its two-hundred day moving average is $162.76.

Masimo (NASDAQ:MASI - Get Free Report) last issued its earnings results on Tuesday, August 5th. The medical equipment provider reported $1.33 EPS for the quarter, beating analysts' consensus estimates of $1.22 by $0.11. The business had revenue of $370.90 million during the quarter, compared to analyst estimates of $368.65 million. Masimo had a positive return on equity of 26.54% and a negative net margin of 24.85%.The firm's revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.86 EPS. Sell-side analysts predict that Masimo Corporation will post 4.1 EPS for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.